|
|
Metabolic Alkalosis: A Real Danger of Overdiuresis in Patients with Heart Failure |
Yaseen Ali, Amila M. Parekh, Rahul K. Rao, Mirza R. Baig |
Department of Medicine, Ohio University, 120 Chibb Hall, Athens, Ohio, 45701, United States |
|
|
Abstract
Chronic heart failure is one of the most common reasons for hospital admissions in the United States. A patient is diagnosed with heart failure when the heart is unable to do its physiological work of pumping the blood to the peripheral organs. At this time, the excess volume of fluid can accumulate easily, leading to signs of fluid overload. Loop diuretics has been at the forefront to alleviate these symptoms. It has its own side effects, but a lesser known and monitored is metabolic alkalosis. Herein, we reviewed a case where a patient developed metabolic alkalosis due to loop diuretics.
|
|
|
|
|
1 Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation, 2012, 125(1): e2-220.
8 Geara AS, El-Imad T, Stern L. Prolonged immobilization as a potential etiology of metabolic alkalosis in hemodialysis patients. Am J Kidney Dis, 2011, 58(6): 1040-1. |
[1] |
TAN Mi-duo. Research Progress of Translational Medicine in Breast Cancer[J]. Journal of International Translational Medicine, 2017, 5(2): 86-91. |
[2] |
Lukas Gietz, Benjamin Mayer. A Resampling Approach for Sample Size Estimation in Animal Experiments[J]. Journal of International Translational Medicine, 2017, 5(2): 53-62. |
[3] |
QIAN Ting, HUANG Xin-en. Comparison of the Efficacy and Safety of Pemetrexed-Based Versus Paclitaxel-Based Chemotherapy as Third-Line Treatment for Patients with Advanced Breast Cancer[J]. Journal of International Translational Medicine, 2017, 5(2): 63-66. |
[4] |
MAO Xiao-dong, ZHE Yi, CHEN Ya-jun, LIU Kang-sheng. Detection of Serum Anti-Müllerian Hormone Level for Women of Reproductive Age: A Cross-Sectional Study[J]. Journal of International Translational Medicine, 2017, 5(2): 67-70. |
[5] |
LIU Yong-jun, ZHOU Yan. Advances of PD-1/PD-L1 Inhibitors in Tumor Immunotherapy[J]. Journal of International Translational Medicine, 2017, 5(2): 80-85. |
[6] |
WANG Peng. Chimeric Antigen Receptor-Engineered T Cells in Tumor Immunotherapy: From Bench to Beside[J]. Journal of International Translational Medicine, 2017, 5(2): 92-97. |
|
|
|
|